Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial-Reference-Cited by-同舟云学术

Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial

Published:2013-02-11 Issue:3 Volume:57 Page:974-984
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sulkowski Mark S.,Poordad Fred,Manns Michael P.,Bronowicki Jean-Pierre,Rajender Reddy K.,Harrison Stephen A.,Afdhal Nezam H.,Sings Heather L.,Pedicone Lisa D.,Koury Kenneth J.,Sniukiene Vilma,Burroughs Margaret H.,Albrecht Janice K.,Brass Clifford A.,Jacobson Ira M.,

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26096/fullpdf

Reference23 articles.

1. The natural history of hepatitis C virus (HCV) infection;Chen;Int J Med Sci,2006

2. Hepatitis C virus infection;Lauer;N Engl J Med,2001

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

5. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic, renal, and hematological changes in chronic hepatitis C patients achieving rapid virologic response after 12 weeks of direct-acting antiviral treatment: A prospective cohort study;PLOS ONE;2023-09-01

2. EASL recommendations on treatment of hepatitis C: Final update of the series☆;Journal of Hepatology;2020-11

3. Treatment of chronic hepatitis C virus infection with crushed ledipasvir/sofosbuvir administered through a percutaneous endoscopic gastrostomy tube in a patient with HIV coinfection;American Journal of Health-System Pharmacy;2020-10-10

4. EASL Recommendations on Treatment of Hepatitis C 2018;Journal of Hepatology;2018-08

5. Anti-anemia effects of ginsenoside Rk3 and ginsenoside Rh4 on mice with ribavirin-induced anemia;Food & Function;2018